These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 19425267)

  • 1. [Relief of upper urinary tract].
    Mortensen J
    Ugeskr Laeger; 2009 Apr; 171(18):1539; author reply 1539. PubMed ID: 19425267
    [No Abstract]   [Full Text] [Related]  

  • 2. [Relief of upper urinary tract obstruction in patients with cancer of the prostate].
    Kraemer PC; Borre M
    Ugeskr Laeger; 2009 Mar; 171(11):873-6. PubMed ID: 19278608
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Palliative Subcutaneous Tunneled Nephrostomy Tube (PSTN): a simple and effective technique for management of malignant extrinsic ureteral obstruction.
    Bell DG; Fischer MA
    Can J Urol; 2002 Feb; 9(1):1470-4. PubMed ID: 11886602
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Nephrostomy. Relief of upper urinary tract in non-malignant and malignant diseases].
    Walter S
    Ugeskr Laeger; 2009 Mar; 171(11):871. PubMed ID: 19278607
    [No Abstract]   [Full Text] [Related]  

  • 5. Management of extrinsic malignant ureteral obstruction with urinary diversion.
    Kanou T; Fujiyama C; Nishimura K; Tokuda Y; Uozumi J; Masaki Z
    Int J Urol; 2007 Aug; 14(8):689-92. PubMed ID: 17681056
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Percutaneous nephrostomy in malignant urinary tract obstruction.
    Bhandari M; Sinha S
    Natl Med J India; 1993; 6(5):218. PubMed ID: 8241936
    [No Abstract]   [Full Text] [Related]  

  • 7. [Diversions of the upper urinary tract] in oncologic patients].
    Mohamed Mohamed-Abdallah Z; Esteban Fuertes M; Hermida Gutiérrez J; Chicharro Almarza GJ; Luengo Alpuente S; Ramírez Fernández JC; Resel Estévez L
    Actas Urol Esp; 1994 May; 18 Suppl():465-7. PubMed ID: 8073936
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Percutaneous urinary diversion in patients with hormone-refractory prostate cancer.
    Dowling RA; Carrasco CH; Babaian RJ
    Urology; 1991 Feb; 37(2):89-91. PubMed ID: 1992595
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of urinary tract obstruction by cancer of the prostate.
    Vicente J; Chéchile G
    Prog Clin Biol Res; 1989; 303():287-97. PubMed ID: 2674991
    [No Abstract]   [Full Text] [Related]  

  • 10. [Therapeutic tactics in obstructive forms of prostatic cancer (2 cases)].
    Zil'berman MN
    Vopr Onkol; 1987; 33(5):89-91. PubMed ID: 3590674
    [No Abstract]   [Full Text] [Related]  

  • 11. Maintaining quality of life after palliative diversion for malignant ureteral obstruction.
    Markowitz DM; Wong KT; Laffey KJ; Bixon R; Nagler HM; Martin EC
    Urol Radiol; 1989; 11(3):129-32. PubMed ID: 2480679
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ureteral obstruction associated with prostate cancer: the outcome after ultrasonographic percutaneous nephrostomy.
    Bordinazzo R; Benecchi L; Cazzaniga A; Vercesi A; Privitera O
    Arch Ital Urol Androl; 1994 Sep; 66(4 Suppl):101-6. PubMed ID: 7889041
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Upper urinary tract cancer--challenges for the urologist.
    Bostrom PJ; Soloway MS
    J Urol; 2007 Jul; 178(1):12-3. PubMed ID: 17574051
    [No Abstract]   [Full Text] [Related]  

  • 14. [Percutaneous nephrostomy at the Second Kaunas Clinical Hospital].
    Matjosaitis A; Rinkūnas G; Bosas P
    Medicina (Kaunas); 2002; 38 Suppl 1():76-8. PubMed ID: 12556641
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Percutaneous nephrostomy for ureteral obstruction caused by malignancy].
    Nägelein R
    Dtsch Med Wochenschr; 1997 Mar; 122(12):385. PubMed ID: 9118796
    [No Abstract]   [Full Text] [Related]  

  • 16. Cutaneous calicostomy for salvage urinary diversion.
    Canon SJ; Jayanthi VR
    J Pediatr Urol; 2008 Jun; 4(3):239-42. PubMed ID: 18631936
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Re: Subcutaneous urinary diversions for palliative treatment of pelvic malignancies.
    Irani J; Aubert J
    J Urol; 1996 Sep; 156(3):1137. PubMed ID: 8709328
    [No Abstract]   [Full Text] [Related]  

  • 18. [Indications and methods of invasive minimal urinary derivations in oncology].
    Praz V; Chollet Y; Jichlinski P
    Rev Med Suisse; 2007 Dec; 3(136):2788-90, 2792. PubMed ID: 18183814
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Percutaneous nephrostomy: experience in 107 kidneys.
    Ho PC; Talner LB; Parsons CL; Schmidt JD
    Urology; 1980 Nov; 16(5):532-5. PubMed ID: 7445298
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Percutaneous nephrostomy in the treatment of mechanical complications of ureteral diversions].
    Cornud F; Billebaud T; Delmas V; Meuriot N; Moulonguet A
    J Urol (Paris); 1987; 93(2):103. PubMed ID: 3585039
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.